Stock A217950 PHARMARESEARCH BIO CO., LTD.
Add to a list
To use this feature you must be a member
Log inSign up

News PHARMARESEARCH BIO Co., Ltd.

Equities

A217950

KR7217950005

End-of-day quote Korea S.E.
Other stock markets
 06:00:00 2024-05-16 pm EDT 		5-day change 1st Jan Change
29,750 KRW -1.16% Intraday chart for PHARMARESEARCH BIO Co., Ltd. -2.14% +48.01%
Feb. 22 PHARMARESEARCH BIO Co., Ltd. announced that it has received KRW 10 billion in funding from Shinhan Capital Co., Ltd. CI
Feb. 19 PHARMARESEARCH BIO Co., Ltd. announced that it expects to receive KRW 10 billion in funding from Shinhan Capital Co., Ltd. CI

Summary

Search
See the results
Unlock all the news on all businesses: Never miss an investment opportunity again!
100% Free Registration
PHARMARESEARCH BIO Co., Ltd. announced that it has received KRW 10 billion in funding from Shinhan Capital Co., Ltd.
CI
PHARMARESEARCH BIO Co., Ltd. announced that it expects to receive KRW 10 billion in funding from Shinhan Capital Co., Ltd.
CI
PHARMA RESEARCH BIO Co., Ltd. announced that it has received KRW 30 billion in funding from PharmaResearch Co., Ltd.
CI
PHARMA RESEARCH BIO Co., Ltd. announced that it expects to receive KRW 30 billion in funding from PharmaResearch Co., Ltd.
CI
Dongho Song cancelled the acquisition of G Biologics Co., Ltd. from PHARMA RESEARCH BIO Co., Ltd..
CI
Dongho Song agreed to acquire G Biologics Co., Ltd. from PHARMA RESEARCH BIO Co., Ltd. for KRW 5.2 billion.
CI
Sangsoo Jung and others acquired 26.2% stake in Pharma Research Bio Co., Ltd. from Dong-Ho Song for KRW 16.5 billion.
CI
Dong-Ho Song acquired an additional 0.034% stake in Pharma Research Bio Co., Ltd. from KDB Capital Corp.for KRW 30.5 million.
CI
Dong-Ho Song acquired an additional 1.9% stake in Pharma Research Bio Co., Ltd. from KDB Capital Corp.for KRW 1.7 billion.
CI
Dong-Ho Song acquired an additional 2.8% stake in Pharma Research Bio Co., Ltd. from Meritz Securities Co., Ltd, Investment Arm for KRW 2.2 billion.
CI
Sangsoo Jung and others acquired 26.2% in Pharma Research Bio Co., Ltd. from Dong-Ho Song for KRW 16.5 billion.
CI
BIOCND Inc. announced that it has received KRW 10 billion in funding from Pharma Research Products Co., Ltd
CI
Pharma Research Products Co., Ltd completed the acquisition of 42.45% stake in BIOCND Inc. from a group of shareholders.
CI
BIOCND Inc. announced that it expects to receive KRW 10 billion in funding from Pharma Research Products Co., Ltd
CI
Pharma Research Products Co., Ltd signed a memorandum of understanding to acquire 42.45% stake in BIOCND Inc. from a group of shareholders for KRW 25.9 billion.
CI
PHARMA RESEARCH BIO Co., Ltd. announced that it has received KRW 1.5 billion in funding
CI
PHARMA RESEARCH BIO Co., Ltd. announced that it has received KRW 1 billion in funding from Dt& Investment Co.,Ltd.
CI
PHARMA RESEARCH BIO Co., Ltd. announced that it expects to receive KRW 1 billion in funding from Dt& Investment Co.,Ltd.
CI
BIOCND Inc. completed the acquisition of remaining 60.12% stake in Wonjin BCD Co., Ltd.
CI
BIOCND Inc. signed a merger contract to acquire remaining 60.12% stake in Wonjin BCD Co., Ltd.
CI
No results for this search
All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

Search

Announcement Date

Since

Until

  1. Stock Market
  2. Equities
  3. A217950 Stock
  4. News PHARMARESEARCH BIO Co., Ltd.
-40% Limited Time Offer: Our subscriptions help you unlock hidden opportunities.
BENEFIT NOW